Trials / Completed
CompletedNCT01575236
A Randomized Non Crossover Study of the GuardianTM Versus SupremeTM Laryngeal Mask Airway
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 120 (actual)
- Sponsor
- Schulthess Klinik · Academic / Other
- Sex
- Female
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The investigators test the hypothesis that ease of insertion, oropharyngeal leak pressure, fiberoptic position and ease of gastric tube placement differ between the GuardianTM and the LMA SupremeTM in paralyzed, anesthetized patients.
Detailed description
The GuardianTM is a new extraglottic airway device which brings together features of both the LMA ProSealTM (high seal cuff, gastric access and bite block - to facilitate ventilation, airway protection and airway obstruction, respectively) and the LMA UniqueTM (single use - prevention of disease transmission). In the following randomized, non-crossover study, the investigators test the hypothesis that ease of insertion, oropharyngeal leak pressure, fiberoptic position and ease of gastric tube placement differ between the GuardianTM and the LMA SupremeTM in paralyzed, anesthetized patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Guardian Laryngeal Mask | ease of insertion, oropharyngeal seal pressure, fiberoptic position, ease of ventilation, occult blood, gastric insertion |
| DEVICE | Supreme Laryngeal Mask Airway | ease of insertion, oropharyngeal seal pressure, fiberoptic position, ease of ventilation, occult blood, gastric insertion |
Timeline
- Start date
- 2012-03-01
- Primary completion
- 2012-06-01
- Completion
- 2012-07-01
- First posted
- 2012-04-11
- Last updated
- 2012-08-08
Locations
1 site across 1 country: Austria
Source: ClinicalTrials.gov record NCT01575236. Inclusion in this directory is not an endorsement.